NRXP
Nrx Pharmaceuticals Inc
$3
Earnings Summary
Revenue | $0Mn |
Net Profits | $-4.33Mn |
Net Profit Margins | -Inf% |
Highlights
Nrx Pharmaceuticals Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Nrx Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.
Nrx Pharmaceuticals Inc’s net profit jumped 24.28% since last year same period to $-4.33Mn in the Q4 2023. On a quarterly growth basis, Nrx Pharmaceuticals Inc has generated 28.54% jump in its net profits since last 3-months.
Nrx Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Nrx Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Nrx Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.5 |
EPS Estimate Current Year | -0.5 |
Highlights
Nrx Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.5 - a -614.29% fall from last quarter’s estimates.
Nrx Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.5.
Key Ratios
Key ratios of the Nrx Pharmaceuticals Inc post its Q1 2024 earnings
Earning Per Share (EPS) | -0.5 |
Highlights
Nrx Pharmaceuticals Inc’s earning per share (EPS) fell -212.5% since last year same period to -0.5 in the Q1 2024. This indicates that the Nrx Pharmaceuticals Inc has generated -212.5% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-14 | -0.5 | -0.5 | 0% |
₹0 US Stocks a/c Opening Fee